Researchers can now access Integral
Molecular's antibody testing expertise alongside its
extensive collection of virus-like reagents including reporter
viruses, VLPs, and pseudoviruses to acquire critical neutralization
data.
PHILADELPHIA, April 16,
2024 /PRNewswire/ -- Integral Molecular, a leader in
providing safe research reagents for virology, announces the launch
of its Virus Neutralization Assay Services enabling researchers to
rapidly obtain high-quality data to advance their vaccines and
therapeutic antibodies.
Learn more about Integral Molecular's
Neutralization Assay Services
With over 20 years' experience in virology, Integral Molecular
has developed innovative solutions that enable researchers to study
viruses safely and efficiently. These solutions include Reporter
Virus Particles (RVPs), pseudoviruses, virus-like particles
(VLPs), and Influenza TiterSafeTM VLPs for
hemagglutination assays. These virus-like reagents cannot replicate
and are incapable of causing infectious disease, enabling the study
of even the most pathogenic viruses in a standard laboratory
environment.
Integral Molecular's Neutralization Assay Services enable
diverse applications:
- Neutralization profiling for antibodies targeting viral
proteins. Studies employ RVPs including coronaviruses
(SARS-CoV-1, SARS-CoV-2, MERS-CoV), influenza, Zika, dengue, yellow
fever, or custom reporter viruses. RVPs are produced using ISO 9001
certified processes that enable generation of reproducible,
reliable data.
- Neutralization experiments can be conducted for monoclonal
antibodies or preclinical sera using the company's catalog of 100+
reporter viruses or custom variants with specified mutations.
- Antibody cocktail screening to test neutralization with
antibody combinations.
"Our virus research tools have been instrumental in laboratories
worldwide, providing safe alternatives to live viruses," said
Maya Cabot, PhD, Senior Product
Manager at Integral Molecular. "Given the limited access to
dedicated containment facilities for manipulating pathogenic
materials, our Neutralization Assay Services provide vital support
to diverse researchers, especially benefiting smaller companies
with limited laboratory infrastructure."
Integral Molecular's virology research tools have been adopted
by over 100 laboratories worldwide and featured in over 250
publications.
About Integral Molecular
Integral Molecular (integralmolecular.com) is the
industry leader in creating and commercializing transformative
technologies that advance the discovery of therapeutics against
difficult protein targets. With 20+ years of experience focused on
membrane proteins, viruses, and antibodies, Integral Molecular's
technologies have been integrated into the drug discovery pipelines
of over 600 biotech and pharmaceutical companies to help discover
new therapies for cancer, diabetes, autoimmune disorders, and viral
threats such as SARS-CoV-2, Ebola, Zika, and dengue viruses.
Follow Integral Molecular on LinkedIn
Press Contact:
Integral Molecular, Inc.
Soma Banik, PhD, Director of Public Relations
215-966-6061
info@integralmolecular.com
www.integralmolecular.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/integral-molecular-launches-virus-neutralization-assay-services-to-drive-antiviral-discovery-302117113.html
SOURCE Integral Molecular